β 2 adrenergic receptor gene polymorphisms in normal and in patients with myocardial infarction in the eastern province of Saudi Arabia
| dc.contributor.author | Al-Rubaish, Abdullah | |
| dc.contributor.author | Al-Shehri, Abdullah | |
| dc.contributor.author | Al-Ali, Abdullah | |
| dc.contributor.author | Al-Ali, Amein | |
| dc.contributor.author | Al-Nafaie, Awatif | |
| dc.contributor.author | Larbi, Emmanuel | |
| dc.contributor.author | Al-Muhanna, Fahd | |
| dc.contributor.author | Asselberg, Folkert | |
| dc.contributor.author | Al-Faraidy, KhalidShakil, Mohammed | |
| dc.date.accessioned | 2016-10-10T07:31:03Z | |
| dc.date.accessioned | 2021-03-31T08:11:38Z | |
| dc.date.available | 2016-10-10T07:31:03Z | |
| dc.date.available | 2021-03-31T08:11:38Z | |
| dc.date.issued | 2013 | |
| dc.description | pages 25-29 | |
| dc.description.abstract | Single nucleotide polymorphisms (SNPs) of the ?<sub>2</sub> -adrenergic receptor (?<sub>2</sub> -AR) gene have been implicated in the pathogenesis of cardiovascular diseases. This study evaluated two ?<sub>2</sub> -AR SNPs in association with myocardial infarction (MI), namely arginine-glycine (G16R) substitution at codon 16 and glutamine-glutamic (Q27E) substitution at condon 27. bjectives:</b> Therefore, our main objective was to determine the association of these two SNPs among patients with MI with and without type 2 diabetes (T2D). <b>Materials and Methods:</b> Blood samples were collected from 201 MI patients with and without diabetes and from 115 controls and the ?<sub>2</sub> -AR gene polymorphisms at codon 16 and codon 27 were assessed by restriction fragment length polymorphism. The ?<sup>2</sup> test was used to compare differences between groups. <b>Results:</b> The SNPs did not deviate significantly from Hardy-Weinberg equilibrium in the control population. The allele and genotype frequencies of the ?<sub>2</sub> -AR gene polymorphism at codon 16 (G16R) was significantly different between MI cases and controls (?<sup>2</sup> = 10.495, <i>P</i> < 0.05 and ?<sup>2</sup> = 8.849, <i>P</i> < 0.05, respectively). No significant difference in genotype and allele frequencies at codon 27 was shown between these two groups (?<sup>2</sup> = 2.661, <i>P</i> ? 0.05 and ?<sup>2</sup> = 1.587, <i>P</i> ? 0.05, respectively). When the MI patients with and without T2D were pooled together, genotype distribution was different between cases and controls at codon 16 (?<sup>2</sup> = 4.631, <i>P</i> = 0.099) and codon 27 (?<sup>2</sup> = 7.247, <i>P</i> = 0.027). However, no significant differences were found in allele frequencies for codon 16 and codon 27 between the two groups (?<sup>2</sup> = 0.628, <i>P</i> = 0.428; ?<sup>2</sup> = 0.33, <i>P</i> = 0.565, respectively). <b>Conclusion:</b> Our findings indicate a moderate association of the ?<sub>2</sub> -AR G16R gene polymorphism with MI suggesting that this gene plays a universal role in the development of MI across ethnicities. However, there was no association of ?<sub>2</sub> -AR G16R gene polymorphism with diabetic patients with MI. | |
| dc.description.uri | http://www.sjmms.net/text.asp?2013/1/1/25/112913 | |
| dc.identifier.issn | 1658-631X | |
| dc.identifier.uri | http://www.sjmms.net/text.asp?2013/1/1/25/112913 | |
| dc.identifier.uri | https://repository.iau.edu.sa/handle/123456789/7352 | |
| dc.title | β 2 adrenergic receptor gene polymorphisms in normal and in patients with myocardial infarction in the eastern province of Saudi Arabia | en_US |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
